Effect of arsenic trioxide on vascular endothelial growth factor after transarterial chemoembolization in primary carcinoma of liver
Haibo Zhang, Huang Lijian, Zhu Yanjuan
Abstract
Haibo Zhang, Huang Lijian, Zhu Yanjuan
Abstract
Objective: To observe the effect of arsenic trioxide on vascular endothelial growth factor(VEGF) after transarterial chemoembolization in primary carcinoma of liver.Methods: We prospectively studied 30 consecutive primary carcinoma of liver patients after transarterial chemoembolization(TACE),who were randomly divided into a treatment group and a control group.Arsenic trioxide was injected intravenously in patients in the treatment group(n=15),while saline was injected in those in the control group(n=15).The VEGF in serum was tested before TACE and 3,8,or 16 days after TACE.Results: Compared with that before TACE,the VEGF in serum raised significantly 3 days and 8 days after TACE both in the 2 groups.The VEGF level was not significantly different between the 2 groups(P0.05).However,the VEGF level decreased significantly 16 days after TACE in the treatment group,while the VEGF level still raised in the control group(P0.01).Conclusion: Arsenic trioxide may reduce the VEGF level in serum after TACE.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the effect of arsenic trioxide on vascular endothelial growth factor(VEGF) after transarterial chemoembolization in primary carcinoma of liver.Methods: We prospectively studied 30 consecutive primary carcinoma of liver patients after transarterial chemoembolization(TACE),who were randomly divided into a treatment group and a control group.Arsenic trioxide was injected intravenously in patients in the treatment group(n=15),while saline was injected in those in the control group(n=15).The VEGF in serum was tested before TACE and 3,8,or 16 days after TACE.Results: Compared with that before TACE,the VEGF in serum raised significantly 3 days and 8 days after TACE both in the 2 groups.The VEGF level was not significantly different between the 2 groups(P0.05).However,the VEGF level decreased significantly 16 days after TACE in the treatment group,while the VEGF level still raised in the control group(P0.01).Conclusion: Arsenic trioxide may reduce the VEGF level in serum after TACE.
Key concepts: Arsenic trioxide, Medicine, Vascular endothelial growth factor, Gastroenterology, Trioxide, Saline, Hepatocellular carcinoma, Internal medicine